203 related articles for article (PubMed ID: 26381898)
21. Oral delivery of exenatide-loaded hybrid zein nanoparticles for stable blood glucose control and β-cell repair of type 2 diabetes mice.
Bao X; Qian K; Yao P
J Nanobiotechnology; 2020 Apr; 18(1):67. PubMed ID: 32345323
[TBL] [Abstract][Full Text] [Related]
22. Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation.
Chen C; Zheng H; Xu J; Shi X; Li F; Wang X
Daru; 2017 Sep; 25(1):20. PubMed ID: 28870261
[TBL] [Abstract][Full Text] [Related]
23. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
[TBL] [Abstract][Full Text] [Related]
24. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
25. Fc-modified exenatide-loaded nanoparticles for oral delivery to improve hypoglycemic effects in mice.
Shi Y; Sun X; Zhang L; Sun K; Li K; Li Y; Zhang Q
Sci Rep; 2018 Jan; 8(1):726. PubMed ID: 29335533
[TBL] [Abstract][Full Text] [Related]
26. Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
Ahn S; Lee IH; Lee E; Kim H; Kim YC; Jon S
J Control Release; 2013 Sep; 170(2):226-32. PubMed ID: 23747732
[TBL] [Abstract][Full Text] [Related]
27. The promoting effect of enteric materials on the oral absorption of larotaxel-loaded polymer-lipid hybrid nanoparticles.
Gou J; Liang Y; Miao L; Chao Y; Zhang Y; Yin T; He H; Tang X
Eur J Pharm Sci; 2018 Nov; 124():288-294. PubMed ID: 30193858
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo evaluation of a once-weekly formulation of an antidiabetic peptide drug exenatide in an injectable thermogel.
Yu L; Li K; Liu X; Chen C; Bao Y; Ci T; Chen Q; Ding J
J Pharm Sci; 2013 Nov; 102(11):4140-9. PubMed ID: 24114868
[TBL] [Abstract][Full Text] [Related]
29. A new orally available glucagon-like peptide-1 receptor agonist, biotinylated exendin-4, displays improved hypoglycemic effects in db/db mice.
Jin CH; Chae SY; Son S; Kim TH; Um KA; Youn YS; Lee S; Lee KC
J Control Release; 2009 Feb; 133(3):172-7. PubMed ID: 18977255
[TBL] [Abstract][Full Text] [Related]
30. Preparation of exenatide-loaded linear poly(ethylene glycol)-brush poly(l-lysine) block copolymer: potential implications on diabetic nephropathy.
Tong F
Int J Nanomedicine; 2017; 12():4663-4678. PubMed ID: 28721043
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticle strategies for the oral delivery of insulin.
Damgé C; Reis CP; Maincent P
Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles.
Huang Y; Deng S; Luo X; Liu Y; Xu W; Pan J; Wang M; Xia Z
Int J Nanomedicine; 2019; 14():9721-9730. PubMed ID: 31849464
[TBL] [Abstract][Full Text] [Related]
33. The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.
Nguyen HN; Wey SP; Juang JH; Sonaje K; Ho YC; Chuang EY; Hsu CW; Yen TC; Lin KJ; Sung HW
Biomaterials; 2011 Apr; 32(10):2673-82. PubMed ID: 21256586
[TBL] [Abstract][Full Text] [Related]
34. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
35. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
36. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.
Leinung MC; Grasso P
Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403
[TBL] [Abstract][Full Text] [Related]
37. Eudragit L-100 Capsules Aromatize and Quaternerize Chitosan for Insulin Nanoparticle Oral Delivery During Toxic Oxidative Stress in Rat Liver and Kidney.
Mahjub R; Najafabadi FK; Dehkhodaei N; Kheiripour N; Ahmadabadi AN; Asl SS; Taheri-Azandariani M; Ranjbar A
Pharm Nanotechnol; 2020; 8(3):239-254. PubMed ID: 32600243
[TBL] [Abstract][Full Text] [Related]
38. A novel vitamin B12-nanosphere conjugate carrier system for peroral delivery of insulin.
Chalasani KB; Russell-Jones GJ; Yandrapu SK; Diwan PV; Jain SK
J Control Release; 2007 Feb; 117(3):421-9. PubMed ID: 17239471
[TBL] [Abstract][Full Text] [Related]
39. Entrapping of Nanoparticles in Yeast Cell Wall Microparticles for Macrophage-Targeted Oral Delivery of Cabazitaxel.
Ren T; Gou J; Sun W; Tao X; Tan X; Wang P; Zhang Y; He H; Yin T; Tang X
Mol Pharm; 2018 Jul; 15(7):2870-2882. PubMed ID: 29863879
[TBL] [Abstract][Full Text] [Related]
40. Oral insulin delivery in rats by nanoparticles prepared with non-toxic solvents.
Viehof A; Javot L; Béduneau A; Pellequer Y; Lamprecht A
Int J Pharm; 2013 Feb; 443(1-2):169-74. PubMed ID: 23328680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
